Improving the tools in the fight against cytomegalovirus or strengthening David to defeat Goliath
- PMID: 17609599
- DOI: 10.1097/QCO.0b013e328285dfb2
Improving the tools in the fight against cytomegalovirus or strengthening David to defeat Goliath
Comment on
-
The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'.Curr Opin Infect Dis. 2007 Aug;20(4):399-407. doi: 10.1097/QCO.0b013e328285a358. Curr Opin Infect Dis. 2007. PMID: 17609600 Review.
-
Cytomegalovirus-associated allograft rejection in heart transplant patients.Curr Opin Infect Dis. 2007 Aug;20(4):425-31. doi: 10.1097/QCO.0b013e328259c33b. Curr Opin Infect Dis. 2007. PMID: 17609604 Review.
Similar articles
-
New inhibitors of human cytomegalovirus (HCMV) on the horizon.J Antimicrob Chemother. 2003 May;51(5):1079-83. doi: 10.1093/jac/dkg205. Epub 2003 Apr 14. J Antimicrob Chemother. 2003. PMID: 12697653 Review. No abstract available.
-
[Cytomegalovirus colitis in a patient with aplastic anemia].Eksp Klin Gastroenterol. 2006;(6):126-30. Eksp Klin Gastroenterol. 2006. PMID: 17612106 Russian. No abstract available.
-
New guidelines for cytomegalovirus infection management in transplant recipients.Herpes. 2008 Oct;15(1):3. Herpes. 2008. PMID: 18983761 No abstract available.
-
Antiviral strategies to combat cytomegalovirus infections in transplant recipients.Curr Opin Pharmacol. 2008 Oct;8(5):541-8. doi: 10.1016/j.coph.2008.07.002. Epub 2008 Aug 25. Curr Opin Pharmacol. 2008. PMID: 18662804 Review.
-
Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus.Clin Infect Dis. 2007 Aug 15;45(4):448-9. doi: 10.1086/519940. Epub 2007 Jul 10. Clin Infect Dis. 2007. PMID: 17638192 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical